comparemela.com
Home
Live Updates
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2022 Resul
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2022 Resul
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2022 Results and Provides Business Update
/PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of...
Related Keywords
United States ,
Netherlands ,
Holland ,
America ,
Robertg Shawah ,
Davidp Luci ,
,
Prnewswire Acurx Pharmaceuticals Inc ,
Drug Administration ,
Nasdaq ,
Exchange Commission ,
Exchange Commission On Form ,
Acurx Pharmaceuticals ,
Anaerobe Society Of America ,
Acurx Pharmaceuticals Inc ,
Leiden University Medical Center Holland ,
University Of Houston ,
Leiden University Medical Center ,
Anaerobe Society ,
Antimicrobial Resistance Conference ,
Chief Executive Officer ,
Chief Financial Officer ,
Gram Positive Selective Spectrum ,
Qualified Infectious Disease Product ,
Generating New Antibiotic Incentives Now ,
Looking Statements ,
Private Securities Litigation Reform Act ,
Paycheck Protection Program ,
Nc ,